Biotech Firm Destiny To Delist From AIM
Destiny Pharma PLC on Monday proposed quitting London's alternative investment market to go private, saying doing so gives it a better chance of raising funds for developing its key drug program...To view the full article, register now.
Already a subscriber? Click here to view full article